This article is mentioned in:

Introduction

Endometriosis is characterized by endometriotic tissue growth outside the uterine cavity. The pathophysiological mechanism of this disorder remains unknown (1). It is a common, chronic, benign, estrogen-dependent, gynecological disorder associated with pelvic pain and infertility (2). Numerous studies have indicated that endometriosis is associated with increased endometrial stromal cell (ESC) survival and invasion, suggesting a link between a heightened menstrual repair response and ectopic endometrial implant formation (3–5). ESC survival and migration is controlled by a complex array of hormones, growth factors, chemokines and inflammatory mediators, involving signaling through phosphatidylinositol-4,5-biphosphate 3-kinase/AKT and mitogen-activated protein kinase (MAPK) pathways, particularly MAPK/c-Jun N-terminal kinase (JNK) signaling (6). Therefore, therapies that inhibit ESC migration and promote apoptosis may have the potential to effectively treat endometriosis.

Mitochondria are central to a variety of cellular physiological processes, including bioenergetic regulation, cellular oxidation-reduction status maintenance and apoptosis induction (7). The mitochondrial network is associated with mitochondrial dynamics and the morphology ranges from a highly interconnected and elongated to a highly fragmented and punctated network (8). The primary mitochondrial dynamics machinery is responsible for mitochondrial membrane fusion and fission. Changes in mitochondrial fission have been reported as an early event occurring in cancer cell proliferation, apoptosis, metabolism, cell motility and migration (9,10). Mitochondrial fission contributes to the mitochondrial pathway of apoptosis via the induction of cardiolipin oxidation by mitochondrial reactive oxygen species (mROS) and mitochondrial permeability transition pore (mPTP) opening, induced by hexokinase 2 (HK2)/voltage-dependent anion channel 1 (VDAC1) dissociation (11). ESC apoptosis and migration are pathogenic factors in endometriosis (12,13). Cell motility is regulated by the balance of F-actin/G-actin. Notably, these actin proteins also facilitate the recruitment of dynamin-related protein 1 (Drp1) to the mitochondria and subsequent mitochondrial fission (14,15). Previous study has confirmed that the accumulation of actin filaments at future fission sites increases the rate of fission, indicating that mitochondrial fission is associated with the migration of malignant cells through the influence of actin homeostasis (16). However, the ability of mitochondrial fission to modulate the apoptosis and migration of ESCs remains unknown.

Zearalenone (ZEA) is a non-steroidal mycotoxin produced by several fungi of the genus Fusarium (17). Accumulating evidence has demonstrated that ZEA may regulate the cancer cell cycle (18), mitochondrial metabolism (19) and apoptosis (20). However, whether ZEA promotes ESC apoptosis through mitochondrial integrity modification remains unknown. Therefore, the role of mitochondrial fission in ESC apoptosis and migration were investigated in the present study. The protective mechanism of ZEA on ESCs was also examined. The results revealed that ZEA induces mitochondrial fission via amplification of the JNK/Drp1 pathway. Furthermore, increased mitochondrial fission caused ESC apoptosis by inducing functional and structural mitochondrial damage. ZEA-mediated mitochondrial fission also impaired ESC migration through the promotion of F-actin depolymerization.

Materials and methods

Ethics statement

The present study was conducted in accordance with the Declaration of Helsinki. The experimental protocol was approved by the Ethics Committee of the Department of Gynecology and Obstetrics, Beijing Tongren Hospital (Beijing, China).

Cell culture

The human ESCs was an American Type Culture Collection (ATCC; Manassas, VA, USA) culture (ATCC-CRL-4003; lot no. 3857441) purchased from LGC Promochem GmbH, Teddington, UK. ESCs were cultured according to ATCC recommendations in RPMI medium (Thermo Fisher Scientific, Inc., Waltham, MA, USA) supplemented with 10% fetal bovine serum (HyClone; GE Healthcare Life Sciences, Logan, UT, USA) (21), 1% L-glutamine and 0.5% gentamycin (Sigma-Aldrich; Merck KGaA, Darmstadt, Germany) at 37°C in 5% CO2. Increasing concentrations of ZEA (1, 5, 10 and 20 µM; Z2125; Sigma-Aldrich; Merck KGaA, Darmstadt, Germany) were applied to ESCs for 24 h once 70–80% confluence was reached (22).

Effects of ZEA on cell viability

To analyze the effects of various ZEA concentrations (1–20 µM) on ESC viability, an MTT assay was performed. ESCs were seeded into a 96-well plate (103 cells/well) (23) and 20 µl MTT (5 mg/ml PBS; pH 7.4; Sigma-Aldrich; Merck KGaA) was subsequently added to the medium for 4 h. The supernatant was discarded and 100 µl dimethyl sulfoxide was added to each well for 10 min. The optical density was measured at 490 nm (24,25).

Cell proliferation, migration and scratch assay

Cell proliferation was measured with a cell counting kit-8 (CCK-8) (Beyotime Institute of Biotechnology, Beijing, China) assay. Cell suspension (200 µl) was seeded in 96-well cell culture plates at a density of 1,000 cells/well and incubated at 37°C for 1–4 days, as previously described (26). Cell migration was analyzed using a Transwell chamber assay (1×105 cells; pore size, 8 µm) with a polycarbonate membrane, as previously described (27,28).

For the scratch assay, cells were cultured in serum-free medium for 24 h and were subsequently scratched with pipette tips, as described previously (29). Wound healing was observed for 48 h and images were captured using a light microscope (Olympus DX51; Olympus Corporation, Tokyo, Japan) every 24 h.

Western blot analysis

Cells were lysed with radioimmunoprecipitation assay buffer (Beyotime Institute of Biotechnology) supplemented with phenylmethylsufonyl fluoride (Beyotime Institute of Biotechnology). Protein concentration was determined using a bicinchoninic acid protein assay. Protein (50 µg) was separated by 10% SDS-PAGE and transferred to polyvinylidene difluoride membranes. The membranes were subsequently blocked with 5% non-fat milk for 1 h at room temperature prior to incubation with the following primary antibodies: GAPDH (1:1,000; 5174; CST Biological Reagents Co., Ltd., Shanghai, China), caspase-3 (1:2,000; 9662; CST Biological Reagents Co., Ltd.), X-linked inhibitor of apoptosis (X–IAP; 1:1,000; 14334; CST Biological Reagents Co., Ltd.), phosphorylated (p-)JNK (1:1,000; 9225; CST Biological Reagents Co., Ltd.), p-Drp1 (1:500; ab193216; Abcam, Cambridge, MA, USA), B-cell lymphoma 2 (Bcl-2; 1:1,000; 15071; CST Biological Reagents Co., Ltd.) associated X protein (Bax; 1:2,000; ab32503), γ-actin (1:1,000; ab123034) and F-actin (1:1,000; ab205; all Abcam) overnight at 4°C (30). The membranes were washed in Tris-buffered saline with Tween-20 for 15 min and were subsequently incubated with horseradish peroxidase-conjugated secondary antibody (1:1,000; sc-2004/sc-2005; Santa Cruz Biotechnology, Inc., Dallas, TX, USA) for 1 h at room temperature. Blots were visualized with an enhanced chemiluminescence substrate kit (Thermo Fisher Scientific, Inc.) (31,32). The bands were scanned and quantified by Quantity One (version 4.6.2; Bio-Rad Laboratories, Inc., Hercules, CA, USA).

Detection of lactate dehydrogenase (LDH) release, mitochondrial membrane potential (ΔΨm), adenosine triphosphate (ATP) production and mPTP opening

LDH released into the medium from injured cells was detected with an LDH cytotoxicity kit (Roche Diagnostics, Indianapolis, IN, USA). ΔΨm was analyzed with a JC-1 kit (Beyotime Institute of Biotechnology, Shanghai, China), according to the manufacturer's protocol (33,34). Cellular ATP was detected using a firefly luciferase-based ATP assay kit (Beyotime Institute of Biotechnology). mPTP opening was visualized as a rapid dissipation of tetramethylrhodamine ethyl ester fluorescence, as described previously (35).

Terminal deoxynucleotidyl transferase dUTP nick end labelling (TUNEL) staining

A TUNEL assay was performed using a one-step TUNEL kit (Beyotime Institute of Biotechnology, Haimen, China), according to the manufacturer's protocol. Briefly, cells were fixed for 1 h in 4% (w/v) paraformaldehyde at room temperature. Following specific labelling, the cells were exposed to DAPI (5 mg/ml) with PBS in the dark for 5 min at room temperature. TUNEL-positive cells were defined as those with fluorescein-dUTP staining present. Then 20 different fields were randomly selected under magnification, ×40 to count the number of apoptotic cells by confocal microscopy (FluoView 1000; Olympus Corporation) (36).

Determination of caspase-3 and caspase-9 activity

Caspase-3 and caspase-9 activities were detected with their respective activity assay kits (C1115 and C1157; Beyotime Institute of Biotechnology), according to the manufacturer's protocol. The assay was repeated three times (37).

Immunocytochemistry

To determine cytochrome c (cyt-c) localization and mitochondrial division, immunocytochemistry was performed (38). Cells (1,000 cells/well) were fixed in 4% paraformaldehyde in PBS for 15 min at room temperature, washed with PBS, and then permeabilized with 0.1% Triton X-100 in PBS for 5 min. Subsequently, the cells were blocked for 1 h with PBS containing 5% bovine serum albumin (Sigma-Aldrich) at room temperature incubated with primary antibodies against cyt-c (1:500; 12963; CST Biological Reagents Co., Ltd.) and translocase of outer mitochondrial membrane 20 (Tom20; 1:500; 42406; CST Biological Reagents Co., Ltd.) for 1 h at room temperature. Mitochondrial fission was observed via Tom20. F-actin was stained with rhodamin-phalloidin (1:100; Molecular Probes; Thermo Fisher Scientific, Inc.) in the dark for 15 min at room temperature. DAPI (1:100, Sigma-Aldrich; Merck KGaA) was used to stain the nuclei in the dark for 5 min at room temperature. Images of the immunostained cells were captured using a fluorescence microscope through a 50× objective (VANOX-S; Olympus Corporation).

ATP production and respiratory chain complex activities assays

The cellular ATP levels were measured using a firefly luciferase-based ATP assay kit (Beyotime, Shanghai, China). Complex I, II, and V activity was measured according to previous studies (7). Mitochondrial respiratory function was measured polarographically at 30°C using a Biological Oxygen Monitor System (Hansatech Instruments, King's Lynn, UK) and a Clarktype oxygen electrode (Hansatech DW1, Norfolk, UK).

Statistical analysis

All analyses were performed with SPSS software version 20.0 (SPSS Inc.; IBM Corp., Armonk, NY, USA). All experiments were repeated three times. All results are expressed as the mean ± standard deviation and statistical significance for each variable was estimated by a one-way analysis of variance followed by Tukey's test for the post hoc analysis. P<0.05 was considered to indicate a statistically significant difference.

Results

ZEA reduces ESC viability and growth

The MTT assay revealed a dose-dependent decrease in cell viability following treatment with ZEA for 24 h (Fig. 1B), indicating that ZEA has a toxic effect on ESC viability. The CCK-8 assay was performed to assess the growth capacity of ESCs treated with ZEA. Compared with the control group, ZEA treatment significantly interfered with the proliferative capacity of ESCs. However, no statistical difference was noted between the groups in the first 12 h of treatment. The growth capacity of ESCs reduced as the ZEA concentration increased (Fig. 1A), suggesting that ZEA reduced ESC proliferation.

Figure 1. ZEA reduces ESC viability and growth. (A) Cell counting kit-8 analysis of the proliferation of ZEA-treated endometrial stromal cells. (B) Endometrial stromal cell viability decreases in a dose-dependent manner following treatment with ZEA (0–20 µM) for 24 h. *P<0.05 vs. control. ZEA, zearalenone; ESC, endometrial stromal cell.

ZEA induces ESC apoptosis through mitochondrial fission

As no significant difference was observed in ESC proliferation following 12 h ZEA treatment, ESCs were treated with ZEA for 24 h in the subsequent experiments to exclude the influence of proliferation on cell numbers (Fig. 2). A TUNEL assay was performed to detect the apoptotic rate of ESCs treated with ZEA. The results demonstrated that ZEA significantly increased the apoptotic rate in ESCs compared with the rate observed in the control group (Fig. 2A and B). Approximately 8.35±2.73% of ESCs were TUNEL-positive in the control group. The percentage of TUNEL-positive cells was significantly increased by ZEA in a concentration-dependent manner: 1 µM/l, 19.35±4.64%; 5 µM/l, 36.58±3.29%; 10 µM/l, 58.37±4.26%; and 20 µM/l, 64.21±4.57% (Fig. 2B). These data indicate that ZEA had a lethal impact on ESCs. Caspase-3 activity was investigated as its activation represents an essential and final step in the apoptotic process, leading to the induction of DNA breakage and subsequent cellular apoptosis (7). Significantly increased caspase-3 activity was observed in the ZEA-treated cells compared with the level of activity in the control group (Fig. 2C). The largest pro-apoptotic effect was detected in the of 20 µM/l ZEA group. Thus, this concentration was used for subsequent experiments.

Figure 2. ZEA induces ESC apoptosis by increasing mitochondrial fission. (A) A TUNEL assay was performed to detect the apoptotic rate of ESCs treated with ZEA. Cells were visualized with a confocal microscope. Scale bar, 50 µm. (B) Cells were counted and the proportion of TUNEL-positive cells was calculated. (C) Changes in caspase-3 activity were detected with an assay kit (D) Mitochondrial fission was observed using Tom20. Scale bar, 10 µm. (E) Mitochondrial length was calculated. (F) Changes in caspase-9 activity were detected with an assay kit. (G) LDH released into the medium from injured cells was detected using an LDH cytotoxicity kit. *P<0.05 vs. Ctrl; #P<0.05 vs. ZEA group. ZEA, zearalenone; ESC, endometrial stromal cell; TUNEL, terminal deoxynucleotidyl transferase dUTP nick end labelling; Tom20, translocase of outer mitochondrial membrane; LDH, lactate dehydrogenase; FCCP, carbonyl cyanide-p-trifluoromethoxyphenylhydrazone; Mdivi1, mitochondrial fission inhibitor; Ctrl, control.

Several studies have identified that mitochondrial fission is a critical process in determining cellular survival and apoptosis (39,40). Changes in mitochondrial morphology were investigated to examine the role of mitochondrial fission in ZEA-mediated cellular apoptosis. The mitochondrial fission inducer, carbonyl cyanide-p-trifluoromethoxyphenylhydrazone (FCCP), and the inhibitor, Mdivi1, were used. Compared with the control group, the ZEA-treated group had a marked increase in the level of fragmented mitochondria, with evidence of rounder mitochondria and increased debris (Fig. 2D). The mitochondrial length was also significantly reduced following treatment with ZEA compared with the length in the control group (Fig. 2E). Mdivi1 application with ZEA markedly blocked the mitochondrial fragmentation mediated by ZEA. FCCP was used as the positive control group and induced substantial amounts of mitochondrial debris. These results indicate that ZEA promoted mitochondrial fission.

To establish whether ZEA induced ESC apoptosis by mitochondrial fission induction, LDH release and caspase-9 activity assays were conducted with and without Mdivi1. Inhibition of mitochondrial fission with Mdivi1 significantly reduced the concentration of LDH detected in the medium compared with the level in the ZEA group (Fig. 2G). Similarly, increased caspase-9 activity in the ZEA treatment group was significantly reduced with Mdivi1 application. Notably, FCCP not only promoted LDH release but also enhanced caspase-9 activity. Similar results were observed in the ZEA group (Fig. 2F). Taken together, these data suggest that ZEA induced ESC apoptosis through the upregulation of mitochondrial fission.

Mitochondrial fission contributes to mitochondrial dysfunction and structural damage

Changes in mitochondrial function and structure were examined to elucidate the mechanism by which mitochondrial fission activates cellular apoptosis (11). The primary function of the mitochondria is to produce adequate ATP to fuel cell metabolism (41,42). Significantly reduced ATP production was detected in the ZEA treatment group when compared with the control group, demonstrating that ZEA treatment reduces the ability of mitochondria to generate sufficient ATP (Fig. 3A). Mdivi1 was demonstrated to reverse the ZEA-mediated decrease in ATP, indicating that ZEA-induced mitochondrial fission is responsible for mitochondrial energy disorder. This functional change was induced by the ZEA-induced structural damage. ΔΨm is fundamental to ATP production (43). Over time, the mitochondrial membrane potential dissipates following ZEA treatment (Fig. 3B and C) and these changes were reversed with the addition of Mdivi1 (Fig. 3D and E). ΔΨm collapse is a marker of increased mitochondrial membrane permeability, which may lead to the leakage of mitochondrial proteins from the mitochondria into the cytoplasm (44). The addition of ZEA resulted in increased mitochondrial release of cyt-c, with evidence of dispersion into the cytoplasm and nucleus (Fig. 3F). Furthermore, ZEA treatment promoted excessive mPTP opening and decreased electron transport chain complex function (ETCx; Fig. 3G and H). Mdivi1 was observed to partially suppress cyt-c diffusion and mPTP opening.

Figure 3. Excessive mitochondrial fission results in mitochondrial dysfunction and structural damage. Changes in (A) ATP production, (B) ETCx I, II, and V activity and (C) mitochondrial permeability mPTP opening were detected in ESCs treated with 20 µM ZEA, 20 µM ZEA + Mdivi1 or FCCP. (D and E) The effect of ZEA (20 µM) on ΔΨm at different time points as detected by a JC-1 assay. Scale bar, 100 µm. (F) The effect of 20 µM ZEA, 20 µM ZEA + Mdivi1 or FCCP on ΔΨm as detected by a JC-1 assay. Scale bar, 20 µm. (G) The ratio of red to green fluorescence in ESCs treated with 20 µM ZEA, 20 µM ZEA + Mdivi1 or FCCP. (H) Immunocytochemical analysis of cyt-c leakage from the mitochondria into the cytoplasm. Scale bar, 10 µm. (I) Western blot analysis of the protein levels of cleaved caspase-3, Bax, Bcl-2 and X-IAP in ESCs treated with 20 µM ZEA, 20 µM ZEA + Mdivi1 or FCCP. GADPH was used as an internal control. (J) Relative quantification of the western blot analysis results. *P<0.05 vs. Ctrl; #P<0.05 vs. ZEA group. ZEA, zearalenone; Mdivi1, mitochondrial fission inhibitor; FCCP, carbonyl cyanide-p-trifluoromethoxyphenylhydrazone; ATP, adenosine triphosphate; ΔΨm, mitochondrial membrane potential; cyt-c, cytochrome c; mPTP, mitochondrial permeability transition pore; ESC, endometrial stromal cell; ETCx, electron transport chain complex; Bcl-2, B-cell lymphoma 2; Bax, Bcl-2 associated X protein; X-IAP, X-linked inhibitor of apoptosis; Ctrl, control.

Western blot analysis

Cyt-c release triggers the formation of the apoptosome, a complex comprising of apoptotic peptidase activating factor 1, cyt-c, dATP (deoxy-adenosine triphosphate) and pro-caspase-9 (45). The apoptosome triggers caspase-9 activation, which subsequently cleaves caspase-3 to its active form. Caspase-3 may then activate the mitochondrial cell death effectors (46). Western blot analysis was used to examine the downstream changes induced by cyt-c leakage. ZEA treatment significantly increased levels of the pro-apoptotic proteins, cleaved caspase-3 and Bax, and decreased the levels of anti-apoptotic proteins, X-IAP and Bcl-2, compared with the levels in the control group. Mdivi1 addition prevented the changes observed in the ZEA-treated cells (Fig. 3I and J). These results identified the potential pathological mechanism of ZEA on ESC apoptosis. ZEA-induced mitochondrial fission may have promoted the destruction of mitochondrial function and structure, which subsequently activated the mitochondrial pathway of apoptosis.

ZEA impairs ESC migration via the activation of mitochondrial fission

A Transwell migration assay was performed to investigate the association between ESC migration and endometriosis progression. As ZEA reduced the number of ESCs through apoptosis induction, ESCs were first treated with ZEA for 24 h. Equal numbers of ESCs (1×105) were collected and placed in the upper chamber of the Transwell plate. After 12 h, the number of ESCs that had migrated to the underside of the insert membranes was counted. As demonstrated in Fig. 4, ZEA treatment for 24 h significantly decreased the migratory ability of ESCs compared with the level observed in the control group. Mitochondrial fission inhibition increased ESC migration, suggesting that mitochondrial fission is involved in the migratory process. As F-actin is the primary stress fiber that is essential for cell mobility (47), it was hypothesized that the decreased migration may be a result of mitochondrial fission-induced F-actin depolymerization. ZEA treatment significantly reduced F-actin fluorescence compared with that observed in the control group, indicating a decrease in F-actin activity (Fig. 4C and D). Fission inhibition by Mdivi1 preserved the filamentary structure of F-actin. Additionally, the decrease in F-actin occurred in parallel with an accumulation of G-actin (Fig. 4E and G), an end-product of F-actin depolymerization (48), suggesting that mitochondrial fission stimulated the dissociation and disrupted the synthesis of F-actin. Mdivi1 reduced the conversion of F-actin to G-actin. These results demonstrate that the ZEA treatment interfered with ESC migration by increasing mitochondrial fission, which influenced the balance of F-actin/G-actin.

Figure 4. ZEA impairs ESC migration via the activation of mitochondrial fission. (A) ESC migration was analyzed using a modified Transwell chamber assay. Scale bar, 100 µm. (B) The percentage of migratory cells was calculated for each treatment group. (C) F-actin was stained with rhodamin-phalloidin and visualized. Scale bar, 10 µm. (D) The F-actin fluorescence intensity for each treatment group was calculated. (E) Western blot analysis was performed to detect the protein expression levels of F-actin and G-actin. The relative expression of (F) F-actin and (G) G-actin was calculated from the results of the western blot analysis. *P<0.05 vs. Ctrl; #P<0.05 vs. ZEA group. ZEA, zearalenone; ESC, endometrial stromal cell; Mdivi1, mitochondrial fission inhibitor; FCCP, carbonyl cyanide-p-trifluoromethoxyphenylhydrazone; Ctrl, control.

ZEA regulates mitochondrial fission by activation of the JNK/Drp1 pathway

JNK and Drp1 levels were analyzed to further elucidate the mechanism of mitochondrial fission regulation by ZEA. Drp1 is a large GTPase that controls mitochondrial fission in mammalian cells, and its active phosphorylation site is a serine at position 616 (Ser616) (40). Drp1 is activated by Ser616 phosphorylation, which may be performed by JNK (39). Therefore, it was speculated that the regulatory effects of ZEA on mitochondrial fission may be due to JNK/Drp1 pathway activation. As demonstrated in Fig. 5, the results revealed that ZEA significantly increased p-JNK levels compared with the levels in the control group, and this increase was inhibited by the JNK pathway inhibitor SP600125 (Fig. 5A and B). JNK inhibition also significantly reduced Drp1 phosphorylation at Ser616 compared with the level observed in the ZEA group, which resulted in a decrease in mitochondrial Drp1 and an increase in cytoplasmic Drp1 compared with that observed in the ZEA group (Fig. 5A, C and E). These data indicate that mitochondrial fission is modulated by the JNK/Drp1 pathway, which in turn is activated by ZEA.

Figure 5. ZEA regulates mitochondrial fission by activating the JNK/Drp1 pathway. (A) Western blot analysis of Drp1, p-Drp1 and p-JNK levels. The relative quantification of (B) p-JNK, (C) p-Drp1, (D) cyto-Drp1 and (E) mito-Drp1 was calculated from the results of the western blot analysis. *P<0.05 vs. Ctrl; #P<0.05 vs. ZEA group. ZEA, zearalenone; p-, phosphorylated; cyto-, cytoplasmic; mito-, mitochondrial; Drp1, dynamin-related protein 1; JNK, c-Jun N-terminal kinase; SP600125, JNK pathway inhibitor.

Discussion

Endometriosis is a gynecological disease defined by ectopic endometrial tissue implantation that forms functional endometriotic lesions that are frequently located in the ovaries and peritoneum (49). Endometriosis affects ~10% of women of a reproductive age and may cause severe pelvic pain and infertility (50). It has also been associated with an elevated risk of ovarian cancer (51). The pathogenesis of endometriosis is poorly defined and there are a limited number of effective treatments to cure the disease or slow its progression (52). The relatively high incidence and lack of effective therapeutic options presents a requirement for a more in-depth understanding of the underlying mechanisms that influence the development and severity of endometriosis (53). It has been demonstrated that the increased migration and reduced apoptosis of ESCs contributes to the progression of endometriosis (38). Therefore, methods to reduce the mobility and enhance the apoptosis of ESCs are vital to improve the clinical outcomes of patients with endometriosis.

ZEA, also known as the F-2 toxin, is a non-steroidal mycotoxin produced by several species of Fusarium (54). It is a common fungal contaminant of cereal crops worldwide and is typically found in feed and grains, including maize, wheat and rye (55). ZEA is structurally similar to estrogen and competes with estradiol for binding to estrogen receptors, and stimulates estrogenic activity, which may cause several physiological alterations in the reproductive tract (56). In vitro study has indicated that ZEA may regulate metabolic processes, including cell proliferation, differentiation and apoptosis (57). The regulatory role of ZEA in endometriosis has also been demonstrated (58). In the present study, ZEA was revealed to induce the apoptosis and impair the migration of ESCs through regulation of the JNK/Drp1 pathway and mitochondrial fission.

The mitochondrion is present in all human body cells, excluding erythrocytes. It is the primary organelle for cell metabolism, signal transmission, cellular survival and apoptosis (59). In addition to the vital function of ATP production, it has also been identified that mitochondrial fission is a prerequisite for intrinsic apoptosis in some forms of cancer (60). An increase in mitochondrial length has been demonstrated to decrease mitochondrial fission and increase mitochondrial fusion, leading to the inhibition of apoptotic initiation and the downstream catabolic process of autophagy (6). In the present study, mitochondrial fission was revealed to be responsible for ESC apoptosis via the induction of structural and functional mitochondrial damage. ZEA-induced mitochondrial fission caused mitochondrial depolarization, which resulted in the leakage of cyt-c into the cytoplasm. An increase in pro-apoptotic and a decrease in anti-apoptotic proteins was detected, indicating that the mitochondrial pathway of apoptosis was activated as a consequence of cyt-c release.

Mitochondrial fission has been revealed to result in VDAC1 oligomerization and HK2 separation from the outer mitochondrial membrane, leading to mPTP opening that is responsible for a reduction in ΔΨm (11). Additionally, an increase of mROS in response to mitochondrial fission has been demonstrated to induce cardiolipin peroxidation, which mediates cyt-c release and the activation of the mitochondrial pathway of apoptosis (61). Similarly, the present study identified that mitochondrial fission was responsible for the apoptosis observed, via the induction of structural and functional mitochondrial damage. ZEA-induced mitochondrial fission was also demonstrated to be involved in ESC migration, and mitochondrial fission inhibition reduced ESC migration. These effects were independent of cellular apoptosis.

As F-actin is the primary stress fiber that directly modulates cellular migration, it was hypothesized that decreased migration was the result of a mitochondrial fission-mediated F-actin imbalance (62). The results confirmed that mitochondrial fission resulted in F-actin depolymerization to G-actin, thereby impeding cell migration. Furthermore, successful mitochondrial fission has been revealed to be dependent on Drp1, the Drp1 receptor and stress fibers (63). Previous study has suggested that the brief accumulation of intracellular F-actin on the surface of mitochondria is a prerequisite for subsequent mitochondrial division (7). Under physiological conditions, F-actin is regularly distributed to certain parts of the cytoplasm that control cell migration through directional cues. The initiation of mitochondrial fission transforms F-actin into G-actin at the outer mitochondrial membrane, through the formation of a contractile ring, which involves Drp1 and its receptor (64). Considering the indispensable nature of F-actin in fission, excessive fission would likely consume large amounts of cytoplasmic F-actin and cause uneven F-actin distribution, leading to the dysregulation of F-actin homeostasis and impaired migration. However, further evidence is required to support this hypothesis.

The JNK/Drp1 pathway was demonstrated to be involved in the regulatory effects of ZEA on mitochondrial fission in the present study. Previous study has identified that activated JNK contributes to Drp1 phosphorylation (65). Drp1 is a large GTPase that translocates into puncta on mitochondria, where it couples guanosine 5′-triphosphate hydrolysis with mitochondrial membrane constriction and fission (66). Drp1 activity is determined by its phosphorylation state. Drp1 phosphorylation at Ser616 results in Drp1 activation (67), and activated Drp1 translocates from the cytoplasm to the surface of the mitochondria to mediate mitochondrial fission. The present study demonstrated that ZEA increased p-JNK levels and p-Drp1. Notably, inhibition of JNK prevents this change. ZEA-induced JNK pathway activation was also responsible for an increase in mitochondrially-located Drp1 and a decrease in cytoplasmic Drp1, suggesting that JNK regulated Drp1 activity and subsequent mitochondrial fission.

Collectively, the results of the present study highlight the important role of mitochondrial fission in ESC apoptosis and migration via the JNK/Drp1 pathway. Thus, the regulation of mitochondrial fission may be an effective target for endometriosis therapy. These data also provide evidence for the use of ZEA as an effective method to increase mitochondrial fission. However, further understanding of the underlying mechanisms is required prior to potential clinical research and application.

Acknowledgements

Not applicable.

Funding

The present study was supported by the National Natural Science Foundation of China (grant no. 81030002).

Availability of data and materials

All data generated or analyzed during the present study are included in this published article.

Authors' contributions

HW and XZ conceived the research; CN, YD and YG performed the experiments; all authors participated in discussing and revising the manuscript.

Ethics approval and consent to participate

All experimental protocols were approved by the Ethics Committee of the Department of Gynecology and Obstetrics, Beijing Tongren Hospital (Beijing, China). The ethics reference no. 2015TS1303525.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

References